Trial intelligence / Profile preview

Noradrenalin vs terlipressin in hepatorenal syndrome

2006-005090-21Phase 2Completed

Sponsor
AOU Città della Salute e della Scienza di Torino
Start
Nov 2006
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 2, randomised trial in hepatorenal syndrome (HRS) comparing Noradrenalin with Terlipressin (2 arms). Primary endpoint: renal function. Started Nov 2006; status: completed.

02

Drugs

norepinephrineterlipressin
03

Conditions

hepatorenal syndrome (HRS)

Beyond the preview

Go deeper on 2006-005090-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005090-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call